Navigation Links
Drug Users Are 'Super-Spreaders' of Hepatitis C, Study Finds
Date:1/31/2013

THURSDAY, Jan. 31 (HealthDay News) -- Each injection drug user with hepatitis C is likely to infect about 20 other people, and half of those transmissions occur in the first two years after the initial infection, new research shows.

The findings indicate that early diagnosis and treatment of hepatitis C in injection drug users -- called "super-spreaders" -- could prevent many cases of hepatitis C, the researchers said.

The hepatitis C virus is spread through contact with infected blood, having sex with an infected person and from mother to baby during childbirth. Hepatitis C can lead to scarring of the liver or liver cancer. Some patients require a liver transplant. There is no vaccine for the disease.

The researchers combined epidemiological and molecular data to determine how hepatitis C spreads in a population.

"For the first time we show that super-spreading in hepatitis C is led by intravenous drug users early in their infection," study author Gkikas Magiorkinis, of the zoology department at the University of Oxford in England, said in a university news release.

"Using this information, we can hopefully soon make a solid argument to support the scaling-up of early diagnosis and antiviral treatment in drug users," Magiorkinis said. "Helping these people and stopping the spread of hepatitis C is our ultimate target."

The study was published Jan. 31 in the journal PLoS Computational Biology.

Up to 180 million people worldwide are infected with hepatitis C, but many don't know it and go undiagnosed for more than 10 years.

"Working out how many people are likely to be infected by each 'super-spreader' of hepatitis C, as well as how soon they will be infected, has been a puzzle for over 20 years," Magiorkinis said.

"Our research has resolved this issue and paves the way for a modeling study to show what kind of public health interventions could really make a difference," he added. He said their approach should also be useful to those studying HIV.

More information

The U.S. National Institute of Allergy and Infectious Diseases has more about hepatitis C.

-- Robert Preidt

SOURCE: University of Oxford, news release, Jan. 31, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. US Drug Watchdog Now Urges Users of Yaz Yasmin Birth Control Pills That Had a Stroke Or Developed Other Serious Medical Conditions to Contact The Johnson Law Group
2. US Drug Watchdog Now Urges Yaz Yasmin Birth Control Pill Users Who Suffered a Pulmonary Embolism or Other Serious Medical Issues to Call the Johnson Law Group-ASAP
3. Bundlevid.Me: New Apple iPhone App Bundlevid Brings Easy Video Journaling to iPhone Users
4. US Drug Watchdog Now Urges Users of Yaz or Yasmin Birth Control Pills Who Suffered A Life Threatening Medical Problem To Call The Johnson Law Group-Immediately
5. The US Drug Watchdog Now Urges Users Of The Birth Control Pills Yaz-Yasmin to Contact The Johnson Law Group For a Legal Review if They Developed Severe Medical Problems
6. New ChairMaster™ Fitness Chair Lets Users Sit and Get Fit
7. Voice Activated PDA for Blind and Low Vision Users from LS&S Now Offered by Rehabmart
8. US Drug Watchdog Now Urges Yaz Yasmin Birth Control Pill Users Who Suffered a Stroke, Blood Clots, or a Heart Attack to Call the Johnson Law Group for a Legal Review
9. US Drug Watchdog Now Urges Users Of The Diabetes Drug Called Actos To Call The Johnson Law Group if They Have Developed Bladder Cancer-Time Is Of The Essence
10. myMEDholiday Comes up with a New Highly Credible Informative Website for Users Looking for Affordable Healthcare Centers Abroad
11. Kids With Autism Common Users of ERs, Study Says
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug Users Are 'Super-Spreaders' of Hepatitis C, Study Finds
(Date:12/9/2016)... Kentucky - Cincinnati, Ohio (PRWEB) , ... December ... ... in the production of miniature, folded, pharmaceutical inserts and outserts. As a ... Serialization Device. This addition will enable Flottman to individually code professional inserts ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... An inventor ... amputees to safely ride all types of amusement park rides. , The patent-pending SAFETY ... unit is easy to use and could be set up in a matter of ...
(Date:12/9/2016)... ... December 09, 2016 , ... "I had a terrible time trying to ... "I thought that if the nebulizer had a more child-friendly design, then children would ... He developed the patent-pending NEBY to avoid the need to deliver medication via a ...
(Date:12/8/2016)... ... December 08, 2016 , ... After enjoying record-breaking attendance at ... for its 33rd Annual Issues & Research Conference, March 2-3, 2017, at ... the conference is “Persistent Challenges and New Opportunities: Using Research to Accelerate the ...
(Date:12/8/2016)... ... 08, 2016 , ... Mirixa Corporation , a leading ... pharmacist-delivered patient care services, has announced the promotions of Karen Litsinger to senior ... of sales. , Litsinger joined Mirixa in 2008 after serving as a ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec 8, 2016 Research and ... Market Analysis and Trends - Adhesion Type, Application, Usability - Forecast ... ... Global Cardiology Electrodes Market is poised to grow at a CAGR ... trends that the market is witnessing include advancements in extracellular microelectrode ...
(Date:12/8/2016)... 8, 2016   TriNetX , the health ... Hospital signed a membership agreement to join ... of new cures. The TriNetX network ... million patients globally, biopharmaceutical companies and contract research ... protocol design, site selection, patient recruitment, and collaborative ...
(Date:12/8/2016)... 2016  Pennsylvania Physician General Dr. Rachel ... Programs Gary Tennis released safe prescribing ... benzodiazepines, developed with the help of a task ... are frequently prescribed for anxiety or insomnia," said ... opioid pain medications, benzodiazepines pose a significant risk ...
Breaking Medicine Technology: